Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- ComplianceQuest 和 Zolon PCS 获选负责美国食品药品监督管理局（FDA）企业质量管理体系的现代化改造佛罗里达州坦帕市, 2026年10月7日 - (亚太商讯) - 领先的人工智能驱动型互联质量、风险与合规（QRC）系统提供商 ComplianceQuest，以及为联邦机构提供安全、以任务为导向的 IT 服务的供应商 Zolon PCS，今日宣布美国食品药品监督管理局（FDA）将基于 ComplianceQuest 平台对其企业质量管理运营进行现代化改造。该项目将根据美国食品药品监督管理局（FDA）的“云质量管理体系总采购协议”（BPA）实施，这是一项为期五年的协议，Zolon PCS作为总承包商中标，ComplianceQuest则担任其平台合作伙伴。 ComplianceQuest 与 Zolon PCS 将通力合作，协助美国食品药品监督管理局（FDA）实施一套基于 Salesforce FedRAMP 政府云平台的现代化、安全且支持人工智能的质量管理解决方案。该解决方案旨在加强合规性、提高一致性、简化质量流程，并为 FDA 各中心和办公室提供更深入的洞察。 该计划将重点关注以下四个优先事项： • 互联的质量运营：整合文件控制、培训、变更、纠正预防措施（CAPA）、审计及其他关键流程，并结合报告功能，以支持各站点、职能部门和组织单位之间的一致执行。 • 可信数据与企业可视性：为质量、风险和合规数据构建集中化基础，实现全机构范围内的端到端可追溯性和实时洞察。 • 智能与自动化：应用人工智能和智能自动化技术，以加速调查进程、挖掘相关洞察、识别新兴风险，并支持更优决策。 • 安全、可扩展的联邦级交付：将一个专为支持庞大用户群体、不断增长的数据量及不断演变的监管要求而构建的平台，与 Zolon PCS 在云计算、网络安全、系统集成及敏捷交付方面的联邦级专业知识相结合。 FDA的这一举措反映了受监管领域内更广泛的转变。随着运营复杂性、监管要求以及质量数据量的不断增加，各组织正从孤立的质量流程转向互联互通的全企业范围解决方案。ComplianceQuest的QRC平台正是为这一模式而打造，它将产品、质量、制造、人员、供应商和客户方面的质量、风险与合规管理整合到一个互联的系统中。 “质量管理正从独立的系统和流程向互联的企业级平台演进，”ComplianceQuest首席执行官普拉尚特·拉杰德兰（Prashanth Rajendran）表示，“我们很荣幸能与Zolon PCS合作，共同支持FDA的质量体系现代化进程。这项工作凸显了业界对能够满足高度监管环境下复杂性、严谨性、安全性及不断演变的要求的技术日益增长的需求。” “我们很荣幸获得 FDA 对我们团队的信任，并为能够支持其至关重要的公共卫生使命而感到自豪，”Zolon PCS 总裁 Goutham Amarneni 表示。“如此大规模的质量管理现代化既需要合适的平台，也需要合适的实施合作伙伴。我们将与 ComplianceQuest 携手，为 FDA 提供一套专为满足联邦运营严格要求而打造的、安全且具备人工智能功能的解决方案。” 关于 ComplianceQuest ComplianceQuest 是领先的基于人工智能的质量、风险与合规（QRC）系统，可在单一系统中整合产品、制造、人员及合作伙伴的质量管理。该平台基于 Salesforce 构建，提供端到端的可视化能力、人工智能驱动的智能分析以及企业级执行能力，助力组织防范风险、确保设计阶段即符合合规要求，并将质量转化为增长的驱动力。 关于 Zolon PCS Zolon PCS, LLC 是 Pioneer Corporate Services 与 Zolon Tech, Inc. 成立的合资企业，致力于为联邦机构提供先进、安全且以任务为导向的 IT 服务和咨询。如需了解更多信息，请访问 zolonpcs.zolontech.com. 媒体联系 ComplianceQuest：[email protected] | 408-458-8343 | www.compliancequest.com 来源：ComplianceQuest Copyright 2026 亚太商讯. All rights reserved. www.acnnewswire.com
- ComplianceQuestComplianceQuest and Zolon PCS Selected to Modernize U.S. Food and Drug Administration (FDA) Enterprise Quality Management SystemTAMPA, FLA., Oct 7, 2026 - ComplianceQuest, a leading provider of AI-powered connected Quality, Risk and Compliance (QRC) systems, and Zolon PCS, a provider of secure, mission-focused IT services to federal agencies, today announced that the U.S. Food and Drug Administration (FDA) will modernize its enterprise quality management operations on the ComplianceQuest platform. The initiative will be delivered under the FDA Cloud Quality Management System Blanket Purchase Agreement (BPA), a five-year agreement awarded to Zolon PCS as prime contractor, with ComplianceQuest as its platform partner. Together, ComplianceQuest and Zolon PCS will help FDA implement a modern, secure, AI-enabled quality management solution built on the Salesforce FedRAMP Government Cloud platform. The solution is designed to strengthen compliance, improve consistency, streamline quality processes, and deliver greater insight across FDA's centers and offices. The initiative will focus on four priorities: Connected Quality Operations: Bringing document control, training, change, CAPA, audits, other key processes coupled with reporting to support consistent execution across the sites, functions, and organizational units. Trusted Data and Enterprise Visibility: Creating a centralized foundation for quality, risk and compliance data with end-to-end traceability and real-time insight across the agency. Intelligence and Automation: Applying AI and intelligent automation to accelerate investigations, surface relevant insights, identify emerging risks, and support better decisions. Secure, Scalable Federal Delivery: Combining a platform built to support large user populations, growing data volumes, and evolving regulatory requirements with Zolon PCS's federal expertise in cloud, cybersecurity, systems integration, and agile delivery. The FDA initiative reflects a broader shift across regulated environments. As operational complexity, regulatory expectations, and quality data volumes grow, organizations are moving beyond individual quality processes toward connected, enterprise-wide approaches. ComplianceQuest's QRC platform is built for this model, unifying Quality, Risk and Compliance across Product, Quality, Manufacturing, People, Suppliers, and Customers on a single, connected system. "Quality management is evolving from individual systems and processes toward connected enterprise platforms," said Prashanth Rajendran, CEO of ComplianceQuest. "We are proud to partner with Zolon PCS to support FDA's quality system modernization. This work highlights the growing need for technology that can meet the complexity, rigor, security, and evolving requirements of highly regulated environments." "We are honored by FDA's confidence in our team and proud to support its vital public health mission," said Goutham Amarneni, President of Zolon PCS. "Modernizing quality management at this scale takes both the right platform and the right delivery partner. Together with ComplianceQuest, we are bringing FDA a secure, AI-enabled solution built for the rigor of federal operations." About ComplianceQuest ComplianceQuest is the leading AI-powered Quality, Risk and Compliance (QRC) system that connects product, manufacturing, people, and partner quality in a single system. Built on Salesforce, the platform delivers end-to-end visibility, AI-driven intelligence, and enterprise-scale execution, enabling organizations to prevent risk, ensure compliance by design, and turn quality into a driver of growth. About Zolon PCS Zolon PCS, LLC is a joint venture between Pioneer Corporate Services and Zolon Tech, Inc., delivering advanced, secure, and mission-focused IT services and consulting to federal agencies. For more information, visit zolonpcs.zolontech.com. Media Contact ComplianceQuest: [email protected] | 408-458-8343 | www.compliancequest.com SOURCE: ComplianceQuest
- Jupiter Neurosciences Announces First Patient Dosed in Phase 2a RESET Trial in Parkinson’s Disease and Exploration of Strategic Options to Maximize Shareholder ValueFirst Patient Dosed with JOTROL™ Marks Major Clinical Milestone for Jupiter Neurosciences’ Phase 2a Study Evaluating Safety, Pharmacokinetics and Biomarkers of JOTROL™ in Patients with Parkinson’s Disease
- Palmetto PublishingPalmetto Publishing Releases Monique Lisbon's New Children's Book About a Preemie's NICU WeekTold in first person rhyme and drawn from the author's own family experience, the newly published picture book follows baby Jaxon through seven days of hospital care and the people who provide it. — Palmetto Publishing has released Jaxon's Stay...
- ARUP LaboratoriesARUP Artificial Intelligence Project Selected for Redtail AI Factory Challenge ProjectARUP Laboratories has been selected for the second cohort of challenge projects in Utah's Redtail AI Factory with its project, "Scaling EventHorizon with Redtail: A Foundation Model for Clinical Flow Cytometry." The award will provide...
- Life Time, Inc.Life Time Announces Plans for New Urban Athletic Club with Panoramic Harbor Views at Boston's Commonwealth Pier45,000-square-foot destination will anchor comprehensive health & wellness offerings within landmark redevelopment while expanding Life Time's presence across Greater Boston — Life Time, (NYSE: LTH), the nation's premier healthy lifestyle brand, today...
- GoogleMaking global public health more proactive with Google Earth AICompanies: Alphabet Inc.Google is helping health leaders overcome reporting lags, forecast disease outbreaks, and deliver care to vulnerable communities.
- DIAGNOS Provides an Update on Stock WarrantsDiagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Corporation dedicated to the early detection of eye-related health using Artificial Intelligence (AI) techniques, provides an update on the stock warrants that were exercised and that have expired in the last two months (the “Period”), as well as the outstanding balance.
- Cigna HealthcareCigna Healthcare Introduces Health Sense To Connect Guidance, Benefits and Clinical Support Around Each Person, Improving Affordability and OutcomesCompanies: The Cigna GroupBy connecting information about each person's health, care and coverage, Health Sense℠ helps people receive continuous personalized support, make informed decisions and act sooner Projected to reduce inefficient health care spending by 10% by 2030, improving affordability for employers...
- Monogram Health Announces Renewed Population Health NCQA Accreditation for Three YearsIndependent accreditation validates Monogram's person-centered, in-home clinical model against the most rigorous population health management benchmarks in the industry
- 60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA60 Degrees plans January 2027 results from its hospitalized babesiosis trial and will seek a pre-sNDA meeting with FDA.
- Dr. Sameena RahmanWhen Women Know Something Is Wrong, But Medicine Doesn't Listen: Dr. Sameena Rahman's New Book Examines the Bias, Culture and Silence Behind Women's Sexual HealthBrown Girls' Disease? A Guide to Sexual Health and Empowerment Through a South Asian Lens challenges patients and clinicians to rethink how women's pain, sexuality and health concerns are understood — What happens when a woman knows something is wrong,...